2025
SJR Q1
JCR Q2 · 2,6
228 eşleşen makale
SCIE
Dergi ayrıntısı
Burns
- Yayıncı
- Elsevier Ltd
- Ülke
- United Kingdom · Western Europe
- Tür
- journal
- ISSN
-
0305417918791409
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 0,725
- Quartile Q1
- H-Index 129
- Atıf/yayın 2,32
- Doküman (3y) 853
- Atıf (3y) 2.047
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 2,6
- 5Y JIF 2,9
- JCI 0,95
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Critical Care and Intensive Care Medicine Q2
- Emergency Medicine Q1
- Medicine (miscellaneous) Q2
- Surgery Q1
Alanlar
- Medicine
WoS kategorileri
- Critical Care Medicine | Dermatology | Surgery
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q2 | 0,725 | 2,6 | 2,9 | 0,95 | Q2 | 129 |
| 2024 | Q1 | Q1 | 0,764 | 2,9 | 3 | 1 | Q1 | 123 |
| 2023 | Q1 | Q1 | 0,682 | 3,2 | 3 | 0,91 | Q2 | 123 |
| 2022 | Q1 | Q2 | 0,714 | 2,7 | 2,8 | 0,81 | Q2 | 123 |
| 2021 | Q2 | Q2 | 0,605 | 2,6 | 2,8 | 0,75 | Q2 | 123 |
| 2020 | Q1 | Q2 | 0,901 | 2,7 | 3,2 | 0,78 | Q2 | 123 |
| 2019 | Q1 | Q2 | 0,909 | 2,1 | 2,3 | 0,72 | Q2 | 123 |
| 2018 | — | Q2 | — | 2,2 | 2,3 | 0,77 | Q2 | — |
| 2017 | Q1 | Q2 | 1,044 | 2,1 | 2,5 | 0,78 | Q2 | 123 |
| 2016 | Q1 | Q2 | 1,035 | 2,1 | 2,2 | — | — | 123 |
| 2015 | Q1 | Q2 | 0,971 | 1,9 | 2,2 | — | — | 123 |
| 2014 | Q1 | Q2 | 0,754 | 1,9 | 2,1 | — | — | 123 |
| 2013 | Q1 | Q2 | 0,815 | 1,8 | 1,9 | — | — | 123 |
| 2012 | Q1 | Q2 | 0,672 | 1,8 | 1,9 | — | — | 123 |
| 2011 | Q1 | Q2 | 0,777 | 2 | 2 | — | — | 123 |
| 2010 | Q1 | Q2 | 0,865 | 1,7 | 1,8 | — | — | 123 |
| 2009 | — | Q2 | — | 1,9 | 2 | — | — | — |
| 2008 | — | Q2 | — | 1,6 | 1,6 | — | — | — |
| 2007 | — | Q3 | — | 1,2 | 1,4 | — | — | — |
| 2006 | — | Q3 | — | 1,1 | — | — | — | — |
| 2005 | — | Q2 | — | 1,2 | — | — | — | — |
| 2004 | — | Q3 | — | 1 | — | — | — | — |
| 2003 | — | Q2 | — | 1,1 | — | — | — | — |
| 2002 | — | Q2 | — | 1 | — | — | — | — |
| 2001 | — | Q2 | — | 0,8 | — | — | — | — |
| 2000 | — | Q2 | — | 0,9 | — | — | — | — |
| 1999 | — | Q3 | — | 0,6 | — | — | — | — |
| 1998 | — | Q2 | — | 0,8 | — | — | — | — |
| 1997 | — | Q4 | — | 0,5 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | CRITICAL CARE MEDICINE | SCIE | Q2 | Q2 | 32/66 |
| 2025 | DERMATOLOGY | SCIE | Q2 | Q2 | 41/99 |
| 2025 | SURGERY | SCIE | Q2 | Q2 | 82/321 |
| 2024 | CRITICAL CARE MEDICINE | SCIE | Q2 | Q2 | 21/62 |
| 2024 | DERMATOLOGY | SCIE | Q2 | Q2 | 30/96 |
| 2024 | SURGERY | SCIE | Q1 | Q1 | 54/314 |
| 2023 | CRITICAL CARE MEDICINE | SCIE | Q2 | Q2 | 14/55 |
| 2023 | DERMATOLOGY | SCIE | Q2 | Q2 | 25/94 |
| 2023 | SURGERY | SCIE | Q1 | Q2 | 43/292 |
| 2022 | CRITICAL CARE MEDICINE | SCIE | Q3 | Q2 | 25/35 |
| 2022 | DERMATOLOGY | SCIE | Q2 | Q2 | 29/70 |
| 2022 | SURGERY | SCIE | Q2 | Q2 | 72/213 |
| 2021 | CRITICAL CARE MEDICINE | SCIE | Q3 | Q2 | 26/35 |
| 2021 | DERMATOLOGY | SCIE | Q3 | Q2 | 39/69 |
| 2021 | SURGERY | SCIE | Q2 | Q2 | 99/213 |
| 2020 | CRITICAL CARE MEDICINE | SCIE | Q3 | Q2 | 23/36 |
| 2020 | DERMATOLOGY | SCIE | Q3 | Q2 | 37/69 |
| 2020 | SURGERY | SCIE | Q2 | Q2 | 88/211 |
| 2019 | CRITICAL CARE MEDICINE | SCIE | Q3 | Q2 | 27/36 |
| 2019 | DERMATOLOGY | SCIE | Q3 | Q2 | 37/68 |
| 2019 | SURGERY | SCIE | Q2 | Q2 | 91/210 |
| 2018 | CRITICAL CARE MEDICINE | SCIE | Q3 | Q2 | 22/33 |
| 2018 | DERMATOLOGY | SCIE | Q2 | Q2 | 30/66 |
| 2018 | SURGERY | SCIE | Q2 | Q2 | 75/203 |
| 2017 | CRITICAL CARE MEDICINE | SCIE | Q3 | Q2 | 22/33 |
| 2017 | DERMATOLOGY | SCIE | Q2 | Q2 | 26/64 |
| 2017 | SURGERY | SCIE | Q2 | Q2 | 81/200 |
| 2016 | CRITICAL CARE MEDICINE | SCIE | Q3 | — | 22/33 |
| 2016 | DERMATOLOGY | SCIE | Q2 | — | 27/63 |
| 2016 | SURGERY | SCIE | Q2 | — | 83/197 |
| 2015 | CRITICAL CARE MEDICINE | SCIE | Q4 | — | 25/33 |
| 2015 | DERMATOLOGY | SCIE | Q2 | — | 23/61 |
| 2015 | SURGERY | SCIE | Q2 | — | 76/200 |
| 2014 | CRITICAL CARE MEDICINE | SCIE | Q4 | — | 21/27 |
| 2014 | DERMATOLOGY | SCIE | Q2 | — | 24/63 |
| 2014 | SURGERY | SCIE | Q2 | — | 80/198 |
| 2013 | CRITICAL CARE MEDICINE | SCIE | Q4 | — | 21/27 |
| 2013 | DERMATOLOGY | SCIE | Q2 | — | 23/61 |
| 2013 | SURGERY | SCIE | Q2 | — | 75/204 |
| 2012 | CRITICAL CARE MEDICINE | SCIE | Q3 | — | 19/27 |
| 2012 | DERMATOLOGY | SCIE | Q2 | — | 22/59 |
| 2012 | SURGERY | SCIE | Q2 | — | 68/199 |
| 2011 | CRITICAL CARE MEDICINE | SCIE | Q3 | — | 19/26 |
| 2011 | DERMATOLOGY | SCIE | Q2 | — | 22/58 |
| 2011 | SURGERY | SCIE | Q2 | — | 61/199 |
| 2010 | CRITICAL CARE MEDICINE | SCIE | Q3 | — | 16/23 |
| 2010 | DERMATOLOGY | SCIE | Q2 | — | 27/55 |
| 2010 | SURGERY | SCIE | Q2 | — | 65/188 |
| 2009 | CRITICAL CARE MEDICINE | SCIE | Q3 | — | 15/22 |
| 2009 | DERMATOLOGY | SCIE | Q2 | — | 19/48 |
| 2009 | SURGERY | SCIE | Q2 | — | 51/167 |
| 2008 | CRITICAL CARE MEDICINE | SCIE | Q4 | — | 17/21 |
| 2008 | DERMATOLOGY | SCIE | Q3 | — | 22/43 |
| 2008 | SURGERY | SCIE | Q2 | — | 60/148 |
| 2007 | CRITICAL CARE MEDICINE | SCIE | Q4 | — | 15/19 |
| 2007 | DERMATOLOGY | SCIE | Q3 | — | 28/41 |
| 2007 | SURGERY | SCIE | Q3 | — | 71/139 |
| 2006 | CRITICAL CARE MEDICINE | SCIE | Q3 | — | 12/18 |
| 2006 | DERMATOLOGY | SCIE | Q3 | — | 27/39 |
| 2006 | SURGERY | SCIE | Q3 | — | 69/137 |
| 2005 | CRITICAL CARE MEDICINE | SCIE | Q3 | — | 12/18 |
| 2005 | DERMATOLOGY | SCIE | Q3 | — | 25/39 |
| 2005 | SURGERY | SCIE | Q2 | — | 56/139 |
| 2004 | CRITICAL CARE MEDICINE | SCIE | Q3 | — | 12/17 |
| 2004 | DERMATOLOGY | SCIE | Q3 | — | 22/38 |
| 2004 | SURGERY | SCIE | Q3 | — | 75/139 |
| 2003 | CRITICAL CARE MEDICINE | SCIE | Q3 | — | 11/16 |
| 2003 | DERMATOLOGY | SCIE | Q3 | — | 21/38 |
| 2003 | SURGERY | SCIE | Q2 | — | 55/141 |
| 2002 | CRITICAL CARE MEDICINE | SCIE | Q3 | — | 9/17 |
| 2002 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q3 | — | 23/40 |
| 2002 | SURGERY | SCIE | Q2 | — | 59/141 |
| 2001 | CRITICAL CARE MEDICINE | SCIE | Q3 | — | 11/17 |
| 2001 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q3 | — | 27/38 |
| 2001 | SURGERY | SCIE | Q2 | — | 69/139 |
| 2000 | CRITICAL CARE MEDICINE | SCIE | Q3 | — | 9/15 |
| 2000 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q3 | — | 22/36 |
| 2000 | SURGERY | SCIE | Q2 | — | 63/136 |
| 1999 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q3 | — | 25/36 |
| 1999 | EMERGENCY MEDICINE & CRITICAL CARE | SCIE | Q3 | — | 14/23 |
| 1999 | SURGERY | SCIE | Q3 | — | 83/131 |
| 1998 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q3 | — | 18/35 |
| 1998 | EMERGENCY MEDICINE & CRITICAL CARE | SCIE | Q3 | — | 13/21 |
| 1998 | SURGERY | SCIE | Q2 | — | 58/128 |
| 1997 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q4 | — | 27/32 |
| 1997 | EMERGENCY MEDICINE & CRITICAL CARE | SCIE | Q4 | — | 16/20 |